Which statement about REMS products is true?

Which statement about REMS products is true?

• A. REMS programs involve risk evaluation and mitigation strategies that require safety monitoring and oversight
• B. REMS products require no safety oversight
• C. REMS products are only vaccines
• D. REMS products contain no safety concerns

Answer: (C)

REMS are programs created for certain medications that have serious safety concerns to make sure benefits still outweigh risks. The essence is to implement risk evaluation and mitigation strategies that require active safety monitoring and oversight. These programs often include safeguards like restricted distribution, certification requirements for prescribers and pharmacies, patient enrollment or monitoring, and ongoing safety reporting. Because safety monitoring and oversight are central to why REMS exist, this statement captures what a REMS program is about. REMS are not limited to vaccines, and they do not imply there are no safety concerns—the whole point is to manage those safety issues. For context, isotretinoin has a well-known REMS program (iPLEDGE) to prevent specific safety risks, illustrating how REMS operate in practice.

REMS are programs created for certain medications that have serious safety concerns to make sure benefits still outweigh risks. The essence is to implement risk evaluation and mitigation strategies that require active safety monitoring and oversight. These programs often include safeguards like restricted distribution, certification requirements for prescribers and pharmacies, patient enrollment or monitoring, and ongoing safety reporting. Because safety monitoring and oversight are central to why REMS exist, this statement captures what a REMS program is about. REMS are not limited to vaccines, and they do not imply there are no safety concerns—the whole point is to manage those safety issues. For context, isotretinoin has a well-known REMS program (iPLEDGE) to prevent specific safety risks, illustrating how REMS operate in practice.